Dr. Megan Miller Awarded Grant to Study Psilocybin-Assisted Therapy among Cancer Patients

Megan Miller Headshot

Megan Miller, PhD, RN, was awarded a grant to support the study Perceptions and Attitudes related to Psilocybin-Assisted Therapy among Cancer Patients who Have been Underrepresented in Research (PATH). The study is funded by the University of Wisconsin—Madison’s Transdisciplinary Center for Research in Psychoactive Substances in the School of Pharmacy. The purpose of this study is to qualitatively explore perceptions and attitudes related to psilocybin-assisted therapy among people with cancer who have been underrepresented in research (people of color, people with limited educational attainment, and people at this intersection).The investigative team includes Drs. Ronit Elk (mentor, Southeast Institute for Innovation in Palliative and Supportive Care at the University of Alabama, Birmingham) and Yvan Beaussant (mentor, Harvard Medical School and Dana-Farber Cancer Institute).